First test of new hope drug for Women's cancers begins
Disease control
Recruiting now
This is the first study in people for a new drug called BL0175. It aims to find a safe dose and see if it can help control advanced breast, ovarian, or endometrial cancers that have stopped responding to standard hormone therapies in postmenopausal women. The study will closely m…
Phase: PHASE1 • Sponsor: Shanghai Best-Link Bioscience, LLC • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC